These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17228453)

  • 1. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Early treatment of sexually transmitted hepatitis C.
    TreatmentUpdate; 2006; 18(2):2-3. PubMed ID: 17228453
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Longer is better for genotype 3 treatment.
    TreatmentUpdate; 2006; 18(2):3-4. PubMed ID: 17228454
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-infections. Predicting recovery from hep C.
    TreatmentUpdate; 2008; 20(4):10-1. PubMed ID: 19248276
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-infections. Fighting fatigue and depression in HCV/HIV co-infection.
    TreatmentUpdate; 2006; 18(1):2-3. PubMed ID: 17228457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sexual transmission of hepatitis C in homosexual men].
    Ruys TA; den Hollander JG; Beld MG; van der Ende ME; van der Meer JT
    Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2309-12. PubMed ID: 15587046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection fighters. Hepatitis C and HIV.
    TreatmentUpdate; 2005; 17(1):7. PubMed ID: 17225318
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals.
    Vogel M; Nattermann J; Baumgarten A; Klausen G; Bieniek B; Schewe K; Jessen H; Boesecke C; Rausch M; Lutz T; Fenske S; Schranzo D; Kümmerle T; Schuler C; Theisen A; Mayr C; Seidel T; Rockstroh JK
    Antivir Ther; 2006; 11(8):1097-101. PubMed ID: 17302380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
    Serpaggi J; Chaix ML; Batisse D; Dupont C; Vallet-Pichard A; Fontaine H; Viard JP; Piketty C; Rouveix E; Rouzioux C; Weiss L; Pol S
    AIDS; 2006 Jan; 20(2):233-40. PubMed ID: 16511416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of hepatitis C in a patient with advanced AIDS and decompensated cirrhosis.
    Johanson FD; Balliram DB
    AIDS Read; 2003 Oct; 13(10):494-6, 500-1. PubMed ID: 14596227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin.
    Hajji H; Gérolami R; Solas C; Moreau J; Colson P
    Int J Antimicrob Agents; 2013 Jun; 41(6):595-7. PubMed ID: 23507411
    [No Abstract]   [Full Text] [Related]  

  • 11. Infection fighters. Hepatitis C--is a cure possible?
    TreatmentUpdate; 2005; 17(1):8-9. PubMed ID: 17225319
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients.
    Nussenblatt V; McLaughlin M; Rehm CA; Lempicki RA; Brann T; Yang J; Proschan M; Highbarger HC; Dewar RL; Imamichi T; Koratich C; Neumann AU; Masur H; Polis MA; Kottilil S
    AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1354-9. PubMed ID: 18184077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 14. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe cholestasis in a patient with acute hepatitis C treated with interferon alpha-2b.
    Mukherjee S; Gilroy RK; Schafer DF
    Am J Gastroenterol; 2002 Aug; 97(8):2152-3. PubMed ID: 12190203
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focus on hepatitis. Baseline HCV VL, CD4 percentage predict HCV treatment response.
    Highleyman L
    IAPAC Mon; 2006 Oct; 12(10):375-6. PubMed ID: 17390500
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical management of asymptomatic HCV carriers].
    Nakamura I; Ochiai K; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):396-9. PubMed ID: 15359829
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HIV agents. Hepatitis C treatment and possible interactions with anti-HIV drugs.
    TreatmentUpdate; 2004; 16(3):2-4. PubMed ID: 17216833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.